Premium
Percutaneous aortic valve replacement in patients with challenging aortoiliofemoral access
Author(s) -
Jilaihawi Hasan,
Spyt Tomasz,
Chin Derek,
Logtens Elaine,
Laborde JeanClaude,
Kovac Jan
Publication year - 2008
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.21630
Subject(s) - medicine , percutaneous , aortic valve , aortic valve replacement , balloon , surgery , radiology , percutaneous coronary intervention , cardiology , stenosis , myocardial infarction
Percutaneous aortic valve replacement (PAVR) offers considerable promise in treating high risk patients with aortic valve disease. Two devices are currently clinically available for transfemoral delivery: the Edwards‐Sapien balloon‐expandable bioprosthesis and the Corevalve self‐expanding bioprosthesis, both of which require careful sizing of the peripheral vasculature. Through a case based discussion, we illustrate that these limits of PAVR technology can be stretched in cases of extraordinary clinical need. We demonstrate that, following a learning curve of “optimal cases,” successful PAVR is also possible in diffusely diseased peripheries of borderline small size or with focal aortoiliofemoral disease amenable to a separate intervention beforehand. © 2008 Wiley‐Liss, Inc.